Introduction
Subacute Sclerosing Panencephalitis (SSPE) is a slow viral disease caused by altered measles virus with a progressive course leading eventually to mortality. There is scarcity of reports of SSPE in HIV infected children in describing its clinical course and progression. Complex interactions of the altered virus with the deranged immune system and alteration of its course with antiretroviral therapy is still being elucidated. Here we report a case of SSPE in a child with HIV infection on antiretroviral therapy for WHO clinical stage IV HIV disease, with a slowly progressive course like that of classical SSPE, that has not been reported previously in literature.
Case Report
A 14-year-old boy presented with five months history of behavioral changes with declining scholastic performance Figure 1 ] was normal. Electroencephalogram (EEG) [ Figure 2 ] showed paroxysmal slow waves in delta range lasting for 1.5-2 seconds, occurring periodically at 18 seconds interval which had 1:1 relation with myoclonic jerks. CSF analysis showed 5 cells (lymphocytes), with protein of 42 mg % and sugar of 69 mg %. His CSF multiplex polymerase chain reaction (PCR) was negative for EBV, adenovirus, HSV, HZV. Measles serology by standard indirect immunofluorescent assay showed Serum: CSF IgG ratio of 20 (Serum: CSF ratio < 64 is considered positive). CSF oligoclonal banding was positive with IgG index of 0.8 and albumin quotient of 9.72 indicating intrathecal synthesis of antibodies. Hence the clinical picture, EEG and positive serology were diagnostic of SSPE. HAART was continued and he was initiated on Isoprinosine 500 mg four times a day along with antiepileptics. He has been under follow-up for past seven months without any worsening of symptoms and is still independent for his activities of daily living and attending school. His CD 4 counts also have been stable at around 900 cells per µl.
Discussion
The neurological complications of measles are acute measles encephalitis, acute disseminated encephalomyelitis, inclusion body encephalitis and subacute sclerosing panencephalitis. Inclusion body encephalitis occurs in immunocompromised individuals, with manifestations occurring within few months of measles infection, with a rapidly progressive course leading to death within a year of onset of the symptoms. [2] Classical SSPE, first described by Dawson in 1934 , is caused by latent measles virus 6-8 years after the primary measles infection. [3] However, early-onset SSPE with a fulminant course has been described in children infected with HIV, as well as those perinatally infected with measles virus, probably due to lack of maternal antibodies and impaired host immunity. [4, 5] Inclusion body encephalitis has also been reported in a hemophiliac with HIV infection and a child with acute leukemia. [6] Both these cases developed encephalitis 2 and 7 months after uncomplicated measles.
A more recent case reported from our institution was a 17-year old boy with perinatally acquired HIV infection in WHO clinical stage IV disease (extra pulmonary tuberculosis) not on HAART, who had a fulminant course of SSPE and died within 12 weeks of onset of symptoms. [7] In contrast, our patient with WHO clinical stage IV HIV infection (past CMV retinitis) and SSPE has been stable in clinical Jabbour's stage II [8] for about seven months and so far seems to follow the natural typical course of SSPE, as described in most immunocompetent individuals. The classic periodic complexes as described by Cobb [9] (1966) occurs every 4-15 seconds, although there has been various reports (Westmoreland et al., 1977) [10] where it occur every 1-5 minutes, depending on the stage and progression of disease. Our patients EEG showed periodic complexes, which were occurring every 18 seconds. This electrophysiological correlate again reemphasizes that our patient has a milder disease severity. Normal MRI brain in our patient, five months into the illness, again probably implies a severity of lesser magnitude. There are issues regarding the duration of maternal antibodies and seroconversion after vaccination in HIV-infected children. We could not comment about the efficacy of measles vaccination in our patient, since he developed measles infection at 5 months of age prior to measles vaccination, which is routinely given by the end of ninth month of life. Measles vaccination is recommended as early as 6 months of life [11] in HIV infected infants as they are more likely to acquire measles before 9 months of age and may not yet be severely immunocompromised at 6 months. [12] The defective lymphocyte helper cells TH1 and its cytokines IFN and IL-2 leads to persistence of altered MV virus and subsequent development of SSPE. [13] The level of impairment of TH1 cell function might dictate the clinical course. Hence a classic presentation and slow progression can also be expected, contrary to most reported cases when the primary disease has been stabilized with HAART. However this area needs further research into the complex interaction of the altered virus and the role of HAART in containing the progression of disease.
Conclusion
The occurrence of classic onset and slow progression of SSPE in a child with congenitally acquired HIV infection is described here. The complex interaction of the altered virus with the preexisting immunodeficiency state and the role of drugs in stabilizing and altering its course need further research. We reemphasize the recommendations of early measles vaccination to prevent measles infection and subsequent SSPE in these children who can otherwise look forward to a good life expectancy in the era of HAART. 
What is known
Subacute Sclerosing Pan Encephalitis with coexisting HIV infection is a scarcely reported entity and the few cases reported so far had a fulminant course resulting in death within few months of onset of the disease manifestation.
What is new
The role of Highly Active Anti Retroviral Therapy (HAART) in containing the progression and altering the course of SSPE remains unknown. Contrary to the reported cases, classic onset and slow progression of SSPE in a HIV infected child can be expected if the primary disease is stabilized by HAART.
